- Q3 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 08, 2024C$1.92 (-28.89%)Earnings
- Q2 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023C$2 (-2.44%)Earnings
- Medexus Pharmaceuticals Inc Annual Shareholders Meeting TranscriptSep 21, 2023
- Medexus Pharmaceuticals Inc at Openexchange Share Series (Virtual) TranscriptAug 14, 2023
- Q1 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023C$2.92 (-0.34%)Earnings
- Q4 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptJun 22, 2023C$1.4 (+12.90%)Earnings
- Medexus Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Q3 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 09, 2023C$1.8 (-1.10%)Earnings
- Q2 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022C$1.78 (-26.45%)Earnings
- Medexus Pharmaceuticals Inc Investor Update Call TranscriptSep 21, 2022
- Medexus Pharmaceuticals Inc Annual Shareholders Meeting TranscriptSep 15, 2022
- Q1 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022C$2.95 (+18.00%)Earnings
- Q4 2022 Medexus Pharmaceuticals Inc Earnings Call TranscriptJun 23, 2022C$1.95 (-9.30%)Earnings
- Medexus Pharmaceuticals Inc to Discuss Treosulfan Data TranscriptJun 06, 2022
- Q3 2022 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 10, 2022C$3.27 (+5.48%)Earnings
- Medexus Pharmaceuticals Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 08, 2022
- Medexus Pharmaceuticals Inc at SNN Network Canada Virtual Event TranscriptDec 08, 2021
- Medexus Pharmaceuticals Inc at Benzinga Global Small Cap Conference (Virtual) TranscriptOct 28, 2021
- Medexus Pharmaceuticals Inc at SNN Network Summer Event (Virtual) TranscriptAug 19, 2021
Q2 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript
Greetings and welcome to the Medexus fiscal second-quarter 2024 earnings call. (Operator Instructions) Please note this conference is being recorded.
I will now turn the conference over to your host, Magda Gardner of Investor Relations. Ma'am, you may begin.
Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals second fiscal quarter 2024 earnings call. On the call this morning are Ken d'Entremont, Chief Executive Officer; and Marcel Konrad, Chief Financial Officer. (Event Instructions)
I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws. Actual results may differ materially from historical results or results anticipated by the forward-looking information. In addition, this discussion will also include non-GAAP measures, such as adjusted net income and loss and adjusted EBITDA, which do not have any standardized meaning under IFRS, and therefore may not be comparable to similar measures presented by other
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)